Comparison of the Effects of Different Manual Therapy Techniques on Mandibular Mobility, Cervical Joint Position Sense, Jaw Function and Anxiety Levels in Individuals With Rheumatoid Arthritis and Temporomandibular Disorders: A Randomized Controlled Trial.

J Oral RehabilMay 23, 2026 (epub)
Clinical ResearchRheumatologyPhysical Medicine & RehabilitationOpen access

Kübra Aktaş, Hakan Polat, Tuba Maden et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial evaluated the effects of soft tissue mobilization (STM) and joint mobilization (JM) on mandibular mobility, cervical joint position sense, jaw function, and anxiety in 57 patients with rheumatoid arthritis and temporomandibular disorders. Both interventions improved outcomes compared to a control group, with JM showing more consistent improvements in mandibular mobility.

Key findings

  • Both STM and JM significantly improved mandibular mobility and anxiety compared to the control group (p < 0.05).
  • The control group experienced deterioration in mouth opening, protrusion, and anxiety over time.
  • Significant improvements in cervical joint position sense were noted in the STM group for multiple movements.
  • No significant differences were found between STM and JM in jaw function or anxiety outcomes.

Why it matters

The findings suggest that both STM and JM are effective, non-invasive treatments for managing temporomandibular disorders in patients with rheumatoid arthritis, potentially improving quality of life and functional outcomes.

Source

PubMed · PMID 42175667Free full text on PubMed Central

Published in J Oral Rehabil. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Rheumatology

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.